Author/Creator: Shaw, A T - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Shaw, A T

1. 1379PDImpact of the EML4-ALK variant on the efficacy of alectinib (ALC) in untreated ALK+ advanced NSCLC (aNSCLC) in the global phase III ALEX study. (23rd October 2018)

Authors:: Dziadziuszko, R; Mok, T S; Camidge, D R; Shaw, A T; Noe, J; Nowicka, M; Liu, T; Mitry, E; Peters, S
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. 1380PDEfficacy of lorlatinib in patients (pts) with ROS1-positive advanced non-small cell lung cancer (NSCLC) and ROS1 kinase domain mutations. (23rd October 2018)

Authors:: Solomon, B J; Martini, J-F; Ou, S-H I; Chiari, R; Soo, R A; Bearz, A; Li, S; Thurm, H; Lin, C-C; Riely, G J; Bauer, T M; Shaw, A T
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. 1396PEfficacy and safety of crizotinib in previously treated patients (Pts) with ALK+ advanced non-small cell lung cancer (NSCLC) aged ≥65 years (y). (23rd October 2018)

Authors:: Moro-Sibilot, D; Ahn, M-J; Halmos, B; Kim, D-W; Riely, G J; Shaw, A T; Yang, P-C; Lanzalone, S; Polli, A; Wilner, K D; De Castro Carpeño, J
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. 1397PLong-term safety of crizotinib in previously treated patients (pts) with ALK-positive advanced/metastatic non-small cell lung cancer (NSCLC). (23rd October 2018)

Authors:: Crinò, L; Ahn, M-J; Han, J-Y; Liu, X; Ou, S-H I; Shaw, A T; Yang, P-C; Shi, Y-K; Lanzalone, S; Polli, A; Wilner, K D; Kim, D-W
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. 1399PImpact of lorlatinib on patient-reported outcomes (PROs) in patients (Pts) with advanced ALK+ or ROS1+ non-small cell lung cancer (NSCLC). (23rd October 2018)

Authors:: Peters, S; Shaw, A T; Besse, B; Felip, E; Solomon, B J; Soo, R A; Bearz, A; Gadgee, S M; Lin, C-C; Kao, S; Seto, T; Masters, E T; Abbattista, A; Clancy, J S; Thurm, H; Reisman, A; Camidge, D R
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study. (12th September 2018)

Authors:: Gadgeel, S; Peters, S; Mok, T; Shaw, A T; Kim, D W; Ou, S I; Pérol, M; Wrona, A; Novello, S; Rosell, R; Zeaiter, A; Liu, T; Nüesch, E; Balas, B; Camidge, D R
Journal:: Annals of oncology
Issue:: Volume 29:Number 11(2018)
Page Start:: 2214
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Correlation of extent of ALK FISH positivity and crizotinib efficacy in three prospective studies of ALK-positive patients with non-small-cell lung cancer. (13th July 2018)

Authors:: Soria, J -C; Ho, S N; Varella-Garcia, M; Iafrate, A J; Solomon, B J; Shaw, A T; Blackhall, F; Mok, T S; Wu, Y -L; Pestova, K; Wilner, K D; Polli, A; Paolini, J; Lanzalone, S; Green, S; Camidge, D R
Journal:: Annals of oncology
Issue:: Volume 29:Number 9(2018)
Page Start:: 1964
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. LBA57Overall survival results of ceritinib in ALKi-naïve patients with ALK-rearranged NSCLC (ASCEND-3). (23rd October 2018)

Authors:: Felip, E; Nishio, M; Orlov, S; Park, K; Yu, C-J; Tsai, C-M; Cobo, M; McKeage, M; Su, W-C; SK Mok, T; Scagliotti, G V; Spigel, D; Passos, V Q; Chen, Z; Shaw, A T
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗